ContextVision AB: Transactions made under the buy-back programme
ContextVision AB: Transactions made under the buy-back programme
Oslo, 2 Dcember -- On 3 September, ContextVision AB ("ContextVision" or the
"Company") announced a share buy-back programme of up to NOK 10,000,000, with
a maximum of 4,000,000 shares, in the period from 5 September 2025 to 5 March
DNB Carnegie, acting under the mandate from ContextVision, has carried out the
following transactions under the buy-back programme:
+---------------------+------------------+----------------+------------------+
| Date | Aggregated daily | Weighted | Total daily |
| | volume (number | average share | transaction |
| | of shares) | price per day | value (NOK) |
| | | (NOK) | |
+---------------------+------------------+----------------+------------------+
| 2025-11-24 | 6 681 | 3,2564 | 22 081,37 |
+---------------------+------------------+----------------+------------------+
| 2025-11-25 | 10 531 | 3,3463 | 35 226,20 |
+---------------------+------------------+----------------+------------------+
| 2025-11-26 | 0 | 0,0000 | |
+---------------------+------------------+----------------+------------------+
| 2025-11-27 | 14 460 | 3,6069 | 52 096,49 |
+---------------------+------------------+----------------+------------------+
| 2025-11-28 | 14 842 | 4,1172 | 62 437,33 |
+---------------------+------------------+----------------+------------------+
| 2025-12-01 | 11 390 | 4,1145 | 46 680,78 |
+---------------------+------------------+----------------+------------------+
| 2025-12-02 | 5 252 | 4,0058 | 20 942,88 |
+---------------------+------------------+----------------+------------------+
| Previously | 518 635 | 4,3159 | 2 262 129,21 |
| disclosed buy-buys | | | |
| under the programme | | | |
| (accumulated) | | | |
+---------------------+------------------+----------------+------------------+
| Accumulated under | 581 791 | 4,1926 | 2 501 594,24 |
| the buy-back | | | |
| programme | | | |
+---------------------+------------------+----------------+------------------+
Following the completion of the above transactions, ContextVision owns a total
of 1 959 953 of own shares, corresponding to 2,53% of ContextVision's share
capital.
An overview of all transactions made under the buy-back programme that have
been carried out during the abovementioned time period is attached to this
report and available at www.newsweb.no (http://www.newsweb.no/).
This is information that ContextVision is obliged to make public pursuant to
the EU Market Abuse Regulation and that is subject to the disclosure
requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.
This stock exchange announcement was published by Richard Hallström, CFO, on
the time and date provided.
For further information, please contact:
Richard Hallström, CFO
Email: [email protected]
About ContextVision AB:
ContextVision is a medical technology software company specialized in image
analysis and artificial intelligence. As the global market leader within image
enhancement, we are a trusted partner to leading manufacturers of ultrasound,
X-ray and MRI equipment around the world. Our expertise is to develop powerful
software products, based on proprietary technology and artificial intelligence
for image-based applications. Our cutting-edge technology helps clinicians
accurately interpret medical images, a crucial foundation for better diagnosis
and treatment. The company, established in 1983, is based in Sweden with local
representation in the U.S., Japan, China and Korea. ContextVision is listed on
the Oslo Stock Exchange under the ticker CONTX.
This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR Article 17. The information was submitted for publication,
through the agency of the contact persons set out above, at 2025-12-02 18:45
CET.